Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Breast Neoplasms 19Neoplasms 5Esophageal Squamous Cell Carcinoma 5Carcinoma, Non-Small-Cell Lung 4Rectal Neoplasms 3Head and Neck Neoplasms 3Carcinoma, Hepatocellular 3Urinary Bladder Neoplasms 2Triple Negative Breast Neoplasms 2Stomach Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Ovarian Neoplasms 2Neoplasm, Residual 2Neoplasm Metastasis 2Lymphoma, Large B-Cell, Diffuse 2Lung Neoplasms 2Esophageal Neoplasms 2Colorectal Neoplasms 2Colonic Neoplasms 2Waldenstrom Macroglobulinemia 1Turcot syndrome 1Testicular Neoplasms 1Surgery 1Stress, Psychological 1Squamous Cell Carcinoma of External Auditory Canal 1Solitary Fibrous Tumor, Pleural 1Seminoma 1Sarcoma 1Recurrence 1Postoperative Complications 1

Interventions

Doxorubicin 27pembrolizumab 24Radiotherapy 20Cyclophosphamide 18Magnetic Resonance Spectroscopy 17Specimen Handling 14Nivolumab 14Ifosfamide 13Gemcitabine 13Biopsy 11Surgical Procedures, Operative 10Radiation 10Temozolomide 9X-Rays 8Ipilimumab 8pazopanib 7fludarabine 7cabozantinib 7Irinotecan 7Blood Specimen Collection 7tazemetostat 6liposomal doxorubicin 6Trabectedin 6Surveys and Questionnaires 6Phantoms, Imaging 6olaparib 5eribulin 5atezolizumab 5Vincristine 5Standard of Care 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Sarcoma × Neoadjuvant Therapy × 1 year × Clear all
NCT06660810 2026-01-15

Neoadjuvant Intralesional Injection of Talimogene Laherparepvec

University of Iowa

Phase 2 Active not recruiting
2 enrolled
Sarcoma

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡